|
KDM4C expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.156960E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.195600E-02 |
| Normal-vs-Stage2 |
1.461530E-02 |
| Normal-vs-Stage3 |
3.840200E-04 |
| Normal-vs-Stage4 |
1.517510E-03 |
| Stage1-vs-Stage2 |
2.692400E-01 |
| Stage1-vs-Stage3 |
3.794200E-02 |
| Stage1-vs-Stage4 |
1.352180E-01 |
| Stage2-vs-Stage3 |
6.982800E-01 |
| Stage2-vs-Stage4 |
7.928400E-01 |
| Stage3-vs-Stage4 |
8.999800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.960120E-03 |
| Normal-vs-AfricanAmerican |
6.097800E-02 |
| Normal-vs-Asian |
1.591880E-02 |
| Caucasian-vs-AfricanAmerican |
9.704800E-01 |
| Caucasian-vs-Asian |
9.252400E-01 |
| AfricanAmerican-vs-Asian |
9.755800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.120900E-03 |
| Normal-vs-Female |
2.075800E-03 |
| Male-vs-Female |
7.924200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.680000E-02 |
| Normal-vs-Age(41-60Yrs) |
1.862060E-03 |
| Normal-vs-Age(61-80Yrs) |
2.794700E-04 |
| Normal-vs-Age(81-100Yrs) |
1.696110E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.213630E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.645960E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.051200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.661600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.855200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.124600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.299900E-03 |
| Classical-VS-Follicular |
7.247600E-01 |
| Classical-VS-Other |
8.098400E-01 |
| Classical-VS-Normal |
4.191500E-02 |
| Tall-VS-Follicular |
2.662400E-02 |
| Tall-VS-Other |
1.769180E-01 |
| Tall-VS-Normal |
2.30350000000046E-05 |
| Follicular-VS-Other |
9.093400E-01 |
| Follicular-VS-Normal |
5.326000E-02 |
| Other-VS-Normal |
2.106800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.359300E-03 |
| Normal-vs-N1 |
4.230100E-04 |
| N0-vs-N1 |
1.476030E-01 |
|
|
